Legal Opinion
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
Court of Appeals for the Federal Circuit
Decided September 29, 2022No. 21-2121PublishedCited by 2 opinions
1Opinion of the Court
Case: 21-2121 Document: 49 Page: 1 Filed: 09/29/2022 United States Court of Appeals for the Federal Circuit ______________________ MYLAN PHARMACEUTICALS INC., Appellant v. MERCK SHARP & DOHME CORP., Appellee ______________________ 2021-2121 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2020- 00040. ______________________ Decided: September 29, 2022 ______________________ ERIC THOMAS WERLINGER, Katten Muchin Rosenman LLP, Washington, DC, argued for appellant. Also repre- sented by JITENDRA MALIK, Charlotte, NC; DEEPRO…
2Cases cited11 opinions
- Consolidated Edison Co. v. National Labor Relations BoardSupreme Court of the United States · 1938
- In Re Robert J. Gartside and Richard C. NortonCourt of Appeals for the Federal Circuit · 2000
- Application of Harold G. Petering and Harry H. FallCourt of Customs and Patent Appeals · 1962
- In Re Wilhelm Elsner. In Re Keith W. ZaryCourt of Appeals for the Federal Circuit · 2004
- Elbit Systems of America, LLC v. Thales Visionix, Inc.Court of Appeals for the Federal Circuit · 2018
6 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Incept LLC v. Palette Life Sciences, Inc.Court of Appeals for the Federal Circuit · 2023
- Incept LLC v. Palette Life Sciences, Inc.Court of Appeals for the Federal Circuit · 2023